Results 161 to 170 of about 20,522 (204)
Treatments with ezetimibe/simvastatin (combined or alone) have been indicated as very promising approaches to strongly reduce cholesterol levels in hyperlipidemic patients.We will discuss the efficacy and safety of ezetimibe/simvastatin and their potential to reduce atheroprogression.
MONTECUCCO, FABRIZIO +2 more
openaire +5 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2011
Ezetimibe is a drug substance which can be used for lowering low-density lipoprotein cholesterol. Its crystal form and polymorphism have been determined using X-ray diffraction and thermal methods. Quantitative and qualitative analysis of Ezetimibe as well as study of its impurities and degradations were summarized in this chapter.
Maria L A D, Lestari +2 more
openaire +3 more sources
Ezetimibe is a drug substance which can be used for lowering low-density lipoprotein cholesterol. Its crystal form and polymorphism have been determined using X-ray diffraction and thermal methods. Quantitative and qualitative analysis of Ezetimibe as well as study of its impurities and degradations were summarized in this chapter.
Maria L A D, Lestari +2 more
openaire +3 more sources
Journal of Pharmaceutical and Biomedical Analysis, 2015
The aminolysis of ezetimibe (1) and the structurally similar (3R*,4S*)-(4-fluorophenyl)-4-(4-hydroxyphenyl)-3-methylazetidin-2-one (4a) giving the corresponding β-aminoamides 2a-d and 5a-c was studied spectrophotometrically under pseudo-first order conditions in aqueous butylamine, 3-methoxypropylamine, 2-methoxyethylamine and 2-hydroxyethylamine ...
Jana, Baťová +2 more
openaire +2 more sources
The aminolysis of ezetimibe (1) and the structurally similar (3R*,4S*)-(4-fluorophenyl)-4-(4-hydroxyphenyl)-3-methylazetidin-2-one (4a) giving the corresponding β-aminoamides 2a-d and 5a-c was studied spectrophotometrically under pseudo-first order conditions in aqueous butylamine, 3-methoxypropylamine, 2-methoxyethylamine and 2-hydroxyethylamine ...
Jana, Baťová +2 more
openaire +2 more sources
The American Journal of Cardiology, 2009
The results of the SANDS substudy 2 require careful interpretation. It was a secondary, nonrandomized, observational study of highly selected subjects who required more lipid lowering than what a statin could provide to achieve the LDL cholesterol goal, and the baseline characteristics were different between the subgroups.
Hiroshi, Ashikaga +2 more
openaire +2 more sources
The results of the SANDS substudy 2 require careful interpretation. It was a secondary, nonrandomized, observational study of highly selected subjects who required more lipid lowering than what a statin could provide to achieve the LDL cholesterol goal, and the baseline characteristics were different between the subgroups.
Hiroshi, Ashikaga +2 more
openaire +2 more sources
Ezetimibe Added to Statin Therapy After Acute Coronary Syndromes
BACKGROUND: Statin therapy reduces low-density lipoprotein (LDL) cholesterol levels and the risk of cardiovascular events, but whether the addition of ezetimibe, a nonstatin drug that reduces intestinal cholesterol absorption, can reduce the rate of ...
Johan Jukema +2 more
exaly +1 more source
Expert Opinion on Investigational Drugs, 2002
Ezetimibe is a cholesterol absorption inhibitor that significantly lowers low- density lipoprotein cholesterol (LDL-C), and favourably affects triglyceride and high-density lipoprotein cholesterol blood levels in monotherapy and in combination with statins.
openaire +2 more sources
Ezetimibe is a cholesterol absorption inhibitor that significantly lowers low- density lipoprotein cholesterol (LDL-C), and favourably affects triglyceride and high-density lipoprotein cholesterol blood levels in monotherapy and in combination with statins.
openaire +2 more sources

